Nasdaq Trails Peers on Volume but Insiders Keep Selling

NDAQ gained just 1.4% over the past week, a muted result against a median gain of 4.5% for its closest exchange and financial data peers. ICE was roughly flat, but MSCI added 5.5%, CME rose 6.2%, and BLK climbed 5.9%. That divergence is not explained by short pressure or borrow stress. It looks more like NDAQ is simply being left behind in a week when financial infrastructure names broadly caught a bid.

The lending market is indifferent to the stock. Borrow availability is essentially unlimited, with shares available to lend running at multiples of current short demand, and this has been the case without interruption for months. Short interest is 1.4% of free float, a level that warrants a single sentence rather than a section. The one-month increase of 32% in short shares sounds dramatic but represents fewer than two million additional shares against a $52 billion market cap. The put/call ratio is the more interesting signal: it hit 0.65 this week, roughly 1.5 standard deviations above its 20-day average of 0.48, and well above the year's low of 0.29. That is not panic-level hedging, but options traders are meaningfully more cautious than they were three weeks ago, when the ratio was running below 0.36.

The Street remains broadly constructive but has been trimming targets ahead of tomorrow's earnings release. Morgan Stanley held its Overweight rating but cut its target by $2 to $118 on October 9. Barclays and TD Cowen both shaved targets by $1 to $2 in the same window, also keeping positive ratings. The lone fresh initiation came from Wells Fargo with an Equal-Weight at $100, a notably more reserved entry point. Against a current price of $94.80, the mean target of $108.75 implies roughly 15% upside, which is where the Street consensus has broadly anchored. Valuation gives little away: the PE has drifted slightly in the 20-day range and the EV/EBITDA of 16.4x has crept up around 1 point over 30 days, a modest re-rating that reflects the stock's recovery from earlier this year rather than any aggressive expansion. Earnings momentum ranks in the 73rd percentile on a 90-day basis, pointing to positive revisions, though the forward earnings growth score is softer at the 41st percentile.

Insider activity is the cleaner signal. NDAQ insiders have net sold $5.5 million worth of stock over the past 90 days, with no open-market purchases recorded. The EVP and Chief Strategy Officer, Jeremy Skule, has run a disciplined pattern of monthly sales under a 10b5-1 plan, each in the $105,000 to $106,000 range. More discretionary is the activity from the President of Capital Access Platforms, Nelson Griggs, who sold 22,020 shares across two transactions in late July totalling just under $2.1 million without a declared plan. The CIO sold 6,000 shares in August for $573,000, also outside a plan. These are not distress signals at these sizes, but the absence of any counter-directional buying from senior management going into a quarterly print is a data point worth noting.

On the activist register, a Schedule 13D/A filed by Argus Seller LP in May 2025 is on the books, with a disclosed stake of 4.44%, below the 5% reporting threshold at the time of the most recent filing. As standard with 13D/G disclosures, that stake is as last reported and the holder could have moved further below 5% without a subsequent filing. Separately, Wikipedia attention for the company is running 1.7 standard deviations above its own 90-day history, a proxy for retail interest that tends to spike around earnings events. With Q3 results due tomorrow morning, the number to track is how Financial Crime Management Technology revenue prints against its approximate 25% growth rate from Q2, and whether Capital Access Platforms shows any acceleration from a recovering IPO market.